Cancer Research and Treatment

REVIEW ARTICLE 2024 January 30 Applicability of Spatial Technology in Cancer Research
This review explores spatial mapping technologies in cancer research, highlighting their crucial role in understanding the complexities of the tumor microenvironment (TME). The TME, which is an intricate ecosystem of diverse cell types, has a significant impact on tumor dynamics...

SPECIAL ARTICLE 2024 March 13 Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2021
Purpose The current study provides national cancer statistics and their secular trends in Korea, including incidence, mortality, survival, and prevalence in 2021. Materials and Methods Incidence, survival, and prevalence rates of cancer were calculated using the Korea National ...

SPECIAL ARTICLE 2024 March 11 Prediction of Cancer Incidence and Mortality in Korea, 2024
Purpose This study aimed to report the projected cancer incidence and mortality for the year 2024 to estimate Korea’s current cancer burden. Materials and Methods Cancer incidence data from 1999 to 2021 were obtained from the Korea National Cancer Incidence Database, and cance...

ORIGINAL ARTICLE 2023 December 6 Health Inequities in Cancer Incidence According to Economic Status and Regions Are Still Existed Even under Universal Health Coverage System in Korea: A Nationwide Population Based Study Using the National Health Insurance Database
Purpose The purpose of this study is to determine the level of health equity in relation to cancer incidence. Materials and Methods We used the National Health Insurance claims data of the National Health Insurance Service between 2005 and 2022 and annual health insurance and...

Current Issue

Volume 56(2); Apr 2024

Volume 56(1); January 2024

Volume 55(4); October 2023

Accepted and E-pub version articles are published online before they appear in a regular issue of the journal. Accepted articles are PDF versions of manuscripts that have been peer reviewed and accepted for publication, but not yet copyedited or typeset, allowing readers the most rapid access to accepted papers. The accepted article remains on this page until the final proof version of the paper is posted in Epub Ahead-of Print page.
Accepted article is given its own Doi, so it can be citable as it has been linked to PubMed.

It may be cited as shown in the following example:
Park IH, Im SA, Jung KH, Sohn JH, Park YH, Lee KS, et al. Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01). Cancer Res Treat. 2018 Feb 14 [Epub]. https://doi.org/10.4143/crt.2017.562.

Case Report

Molecular and Treatment Characteristics of SMARCB1 or SMARCA4-Deficient Undifferentiated Tumor: Retrospective Case Series

Hyeon Gyu Kang, Jiwon Koh, Tae Min Kim, Doo Hee Han, Tae-Bin Won, Dong-Wan Kim, Dong-Young Kim, Bhumsuk Keam

Received December 11, 2023 Accepted February 9, 2024 Published online February 13, 2024
DOI: https://doi.org/10.4143/crt.2023.1308
[Accepted]

Original Articles

CD19-specific CAR-T Cell Treatment of 115 Children and Young Adults with Acute B Lymphoblastic Leukemia: Long-Term Follow-up

Yu Wang, Yu-juan Xue, Ying-xi Zuo, Yue-ping Jia, Ai-dong Lu, Hui-min Zeng, Le-ping Zhang

Received November 9, 2023 Accepted February 8, 2024 Published online February 13, 2024
DOI: https://doi.org/10.4143/crt.2023.1205
[Accepted]

Global Expanded Access Program for Pemigatinib in Patients with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma and Fibroblast Growth Factor Receptor Gene Alterations

Anouk Lindley, Gerald Prager, Michael Bitzer, Timothy C. Burn, Christine F. Lihou, Elisabeth Croft

Received November 8, 2023 Accepted February 6, 2024 Published online February 7, 2024
DOI: https://doi.org/10.4143/crt.2023.1197
[Accepted]

Comparison of Clinicopathogenomic Features and Treatment Outcomes of EGFR and HER2 Exon 20 Insertion Mutations in Non-Small Cell Lung Cancer; Single-Institution Experience

So Heun Lee, Hyehyun Jeong, Deok Hoon Kim, Se Jin Jang, Sang-We Kim, Shinkyo Yoon, Dae Ho Lee

Received November 1, 2023 Accepted January 28, 2024 Published online January 30, 2024
DOI: https://doi.org/10.4143/crt.2023.1177
[Accepted]

Review Article

HER2-low Breast Cancer: Now and in the Future

Sora Kang, Sung-Bae Kim

Received October 17, 2023 Accepted January 28, 2024 Published online January 30, 2024
DOI: https://doi.org/10.4143/crt.2023.1138
[Accepted]

Original Articles

Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid Tumors

Yoon-Koo Kang, Min-Hee Ryu, Yong Sang Hong, Chang-Min Choi, Tae Won Kim, Baek-Yeol Ryoo, Jeong Eun Kim, John R. Weis, Rachel Kingsford, Cheol Hee Park, Seong Jang, Arlo McGinn, Theresa L. Werner, Sunil Sharma

Received August 29, 2023 Accepted January 17, 2024 Published online January 18, 2024
DOI: https://doi.org/10.4143/crt.2023.980
[Accepted]

Single Early Intravesical Instillation of Epirubicin for Preventing Bladder Recurrence After Nephroureterectomy in Upper Urinary Tract Urothelial Carcinoma

Jong Hoon Lee, Chung Un Lee, Jae Hoon Chung, Wan Song, Minyong Kang, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Hwan Sung

Received November 14, 2023 Accepted January 16, 2024 Published online January 17, 2024
DOI: https://doi.org/10.4143/crt.2023.1219
[Accepted]

Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma: A Real-World, Retrospective Study

Junho Lee, Sung Hee Lim, Jae Hoon Chung, Wan Song, Hyun Hwan Sung, Byong Chang Jeong, Se Hoon Park

Received November 15, 2023 Accepted January 15, 2024 Published online January 16, 2024
DOI: https://doi.org/10.4143/crt.2023.1226
[Accepted]

Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular Lymphoma

Sang Eun Yoon, Seung-Ho Shin, Dae Keun Nam, Junhun Cho, Won Seog Kim, Seok Jin Kim

Received July 23, 2023 Accepted January 15, 2024 Published online January 16, 2024
DOI: https://doi.org/10.4143/crt.2023.869
[Accepted]

Contribution of Enhanced Locoregional Control to Improved Overall Survival with Consolidative Durvalumab After Concurrent Chemoradiotherapy in Locally Advanced Non-Small Cell Lung Cancer: Insights from Real-World Data

Jeong Yun Jang, Si Yeol Song, Young Seob Shin, Ha Un Kim, Eun Kyung Choi, Sang-We Kim, Jae Cheol Lee, Dae Ho Lee, Chang-Min Choi, Shinkyo Yoon, Su Ssan Kim

Received September 6, 2023 Accepted January 14, 2024 Published online January 16, 2024
DOI: https://doi.org/10.4143/crt.2023.1014
[Accepted]